MedTrace Logo

Jumpstarting Advance Care Planning With ANAI People

NCT06538493 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-07-01

No results posted yet for this study

Summary

The older Alaska Native/American Indian (ANAI) population is increasing at twice the rate of the general population with a higher burden of serious illness. Older ANAI adults with serious illness are half as likely to have advance directives (AD), indicating a need for improved access to and utilization of advance care planning (ACP) to ensure that medical care aligns with the values, goals, and preferences of ANAI patients and their families throughout the illness trajectory. The major goals of this cluster randomized trial (CRT) are to (1) evaluate the comparative effectiveness of usual care and JUMPSTART- ANAI, a culturally tailored ACP communication intervention, for prompting patient-driven ACP conversations between ANAI adults and primary care providers and to (1) identify key factors to successfully implement the intervention in health systems serving ANAI adults with serious illness.

Conditions

  • Advance Care Planning

Interventions

BEHAVIORAL

JUMPSTART-ANAI

Patient questionnaire about experiences, preferences, and concerns regarding ACP followed by feedback form with "tips" for initiating ACP conversation with provider at next clinical visit.

Sponsors & Collaborators

  • University of Arkansas

    collaborator OTHER

  • University of Washington

    collaborator OTHER

  • University of Colorado, Denver

    collaborator OTHER

  • Alaska Native Tribal Health Consortium

    collaborator OTHER

  • University of Alaska Fairbanks

    collaborator OTHER

  • Southcentral Foundation

    lead OTHER

Principal Investigators

  • Jennifer Shaw, PhD · University of Alaska Fairbanks

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2026-12-30
Completion
2027-05-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06538493 on ClinicalTrials.gov